Ernexa Therapeutics Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations
Ernexa Therapeutics Inc. (ERNA) had Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations of $777.00 thousand as of 2020-12-31, per its 10-K filed 2021-03-11.
Discontinued › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations · last filed 2021-03-11
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $777.00K.
- 2020-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $1.71M.
- 2020-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $2.44M.
- 2020-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations $2.42M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations |
|---|---|
| 2020-12-31 | $777.00K 10-K · filed 2021-03-11 |
| 2020-09-30 | $1.71M 10-Q · filed 2020-11-13 |
| 2020-06-30 | $2.44M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $2.42M 10-Q · filed 2020-05-20 |
| 2019-12-31 | $3.41M 10-K · filed 2021-03-11 |
| 2019-09-30 | $2.78M 10-Q · filed 2020-11-13 |
| 2019-06-30 | $2.98M 10-Q · filed 2020-08-07 |
| 2019-03-31 | $2.92M 10-Q · filed 2020-05-20 |
| 2018-12-31 | $2.79M 10-K · filed 2021-03-11 |
| 2018-09-30 | $3.08M 10-Q · filed 2019-11-01 |
| 2018-06-30 | $3.79M 10-Q · filed 2019-08-12 |
| 2017-12-31 | $3.38M 10-K · filed 2020-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |